205 related articles for article (PubMed ID: 28138303)
1. Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study.
Dereziński P; Klupczynska A; Sawicki W; Pałka JA; Kokot ZJ
Int J Med Sci; 2017; 14(1):1-12. PubMed ID: 28138303
[TBL] [Abstract][Full Text] [Related]
2. Determination of amino acids in urine of patients with prostate cancer and benign prostate growth.
Sroka WD; Boughton BA; Reddy P; Roessner U; Słupski P; Jarzemski P; Dąbrowska A; Markuszewski MJ; Marszałł MP
Eur J Cancer Prev; 2017 Mar; 26(2):131-134. PubMed ID: 27222937
[TBL] [Abstract][Full Text] [Related]
3. Prospective serum metabolomic profiling of lethal prostate cancer.
Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
[TBL] [Abstract][Full Text] [Related]
4. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
[TBL] [Abstract][Full Text] [Related]
6. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
[TBL] [Abstract][Full Text] [Related]
8. The decrease of some serum free amino acids can predict breast cancer diagnosis and progression.
Eniu DT; Romanciuc F; Moraru C; Goidescu I; Eniu D; Staicu A; Rachieriu C; Buiga R; Socaciu C
Scand J Clin Lab Invest; 2019; 79(1-2):17-24. PubMed ID: 30880483
[TBL] [Abstract][Full Text] [Related]
9. A study of low-molecular-weight organic acid urinary profiles in prostate cancer by a new liquid chromatography-tandem mass spectrometry method.
Klupczynska A; Plewa S; Sytek N; Sawicki W; Dereziński P; Matysiak J; Kokot ZJ
J Pharm Biomed Anal; 2018 Sep; 159():229-236. PubMed ID: 29990890
[TBL] [Abstract][Full Text] [Related]
10. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.
Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Taguri M; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
Prostate; 2016 Mar; 76(4):376-82. PubMed ID: 26616365
[TBL] [Abstract][Full Text] [Related]
11. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromatography-mass spectrometry.
Shamsipur M; Naseri MT; Babri M
J Pharm Biomed Anal; 2013; 81-82():65-75. PubMed ID: 23624158
[TBL] [Abstract][Full Text] [Related]
12. GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization.
Wu H; Liu T; Ma C; Xue R; Deng C; Zeng H; Shen X
Anal Bioanal Chem; 2011 Aug; 401(2):635-46. PubMed ID: 21626193
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of detecting prostate cancer by ultraperformance liquid chromatography-mass spectrometry serum metabolomics.
Zang X; Jones CM; Long TQ; Monge ME; Zhou M; Walker LD; Mezencev R; Gray A; McDonald JF; Fernández FM
J Proteome Res; 2014 Jul; 13(7):3444-54. PubMed ID: 24922590
[TBL] [Abstract][Full Text] [Related]
14. Shotgun lipidomics for candidate biomarkers of urinary phospholipids in prostate cancer.
Min HK; Lim S; Chung BC; Moon MH
Anal Bioanal Chem; 2011 Jan; 399(2):823-30. PubMed ID: 20953865
[TBL] [Abstract][Full Text] [Related]
15. Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential New Biomarkers.
Duscharla D; Bhumireddy SR; Lakshetti S; Pospisil H; Murthy PV; Walther R; Sripadi P; Ummanni R
PLoS One; 2016; 11(3):e0150253. PubMed ID: 26958841
[TBL] [Abstract][Full Text] [Related]
16. Validation study of urinary metabolites as potential biomarkers for prostate cancer detection.
Gamagedara S; Kaczmarek AT; Jiang Y; Cheng X; Rupasinghe M; Ma Y
Bioanalysis; 2012 Jun; 4(10):1175-83. PubMed ID: 22651561
[TBL] [Abstract][Full Text] [Related]
17. Quantification of free amino acids and dipeptides using isotope dilution liquid chromatography and electrospray ionization tandem mass spectrometry.
Fonteh AN; Harrington RJ; Harrington MG
Amino Acids; 2007 Feb; 32(2):203-12. PubMed ID: 17031482
[TBL] [Abstract][Full Text] [Related]
18. Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
Giskeødegård GF; Hansen AF; Bertilsson H; Gonzalez SV; Kristiansen KA; Bruheim P; Mjøs SA; Angelsen A; Bathen TF; Tessem MB
Br J Cancer; 2015 Dec; 113(12):1712-9. PubMed ID: 26633561
[TBL] [Abstract][Full Text] [Related]
19. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
[TBL] [Abstract][Full Text] [Related]
20. Urinary estrogen metabolites and prostate cancer risk: a pilot study.
Kosti O; Xu X; Veenstra TD; Hsing AW; Chu LW; Goldman L; Bebu I; Collins S; Dritschilo A; Lynch JH; Goldman R
Prostate; 2011 Apr; 71(5):507-16. PubMed ID: 20886539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
